Update
$Sage Therapeutics (SAGE.US)$ Sage Therapeutics Inc: Sage-324 (Biib124) Did Not Demonstrate a Statistically Significant Dose-Response Relationship on Primary Endpoint
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Trytosaveabit OP : Sage Therapeutics Inc: Do Not Plan to Conduct Further Clinical Development of Sage-324 in Et
买跌不追涨 : Can't go short
Trytosaveabit OP 买跌不追涨 : Sorry. I won’t go short. Don’t believe in it personally! GL
买跌不追涨 Trytosaveabit OP : I also seldom go short![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")